OncoLens

OncoLens

OncoLens

Enabling multi-disciplinary case collaboration in cancer care. We make tumor boards, CoC accreditation and clinical initiatives more efficient and effective.
Founded
2016
Raised
$3.9M
Follow us
Twitter followers
Latest funding
$2,500,000
Venture capital (Series A) - 2020
Atlanta Technology Angels BIP Capital Robbins Fund
$1,350,000
Seed fund - 2019
BIP Capital Atlanta Technology Angels (ATA)
Team Size
9
Employees
$2,500,000 Venture capital (Series A)
Pulse 2.0

Tumor Board And Cancer Treatment Company OncoLens Closes $2.5 Million

FinSMEs

OncoLens Secures $2.5M in Pre-Series A Funding

$1,350,000 Seed fund
FinSMEs

OncoLens Closes $1.35M Seed Funding Round